Move decomposition
Earnings contribution and valuation offset
The market move is separated into the change in trailing earnings power and the offset from relative valuation.
US Equity · NYSE · Earnings Dossier
WST earnings intelligence
West Pharmaceutical Services IncHealthcare · Medical Instruments & Supplies · USD reporting basis
Current earnings profile
Delivery strong, expectations demanding
Results have usually cleared estimates, but price has not consistently rewarded the delivery.
Evidence100/100 · Deep
Next scheduled catalyst
Thursday 22 October 2026
Time unconfirmed · Fiscal period ending 30 Sep 2026
49event risk
Elevated
Countdown70 dayscalendar proximity
EPS estimate2.18 USDprovider consensus
Estimate growth+11.2%versus comparable year-ago actual
Historical movement11.4%average absolute next weekly close
Three-year earnings transmission
Delivered earnings power versus market price
Earnings power is leading market price; the spread is stable and has persisted through 7 updates. Both series begin at 100, so the gap isolates the relative change in price and trailing earnings power.
Market move-8.0%2023-08-18 to 2026-08-07
Earnings move7.7%trailing diluted EPS
Unresolved spread15.7 ptsStable
Current multiple41.7xprice divided by TTM EPS
Relationship pressure41/100Moderate
Model confidence79/100High
Relationship controls
What qualifies the headline spread
Persistent earnings lead
Earnings power has led market price across several updates.
Business quality supportive
Cash generation and operating evidence are broadly supportive.
Fresh improvement awaiting confirmation
Earnings improved at the latest reported update, but market price remains below its pre-update level.
Model qualification
The direction is sensitive to the comparison horizon.
Beat rate91.7%11 beats in 12 measured quarters
Average surprise+13.3%median 14.8%
Delivery streak88 consecutive beats
Average response-1.7%12 measured reactions
Result-price confirmation55%same directional sign
Surprise variability10.1 ptspopulation dispersion
Estimate delivery
Actual EPS versus consensus
Actual and estimated EPS are displayed in reported currency on the same quarterly basis.
Price acceptance
Surprise and next weekly close
The response uses the first completed weekly close after the public report against the prior completed weekly close.
Fundamental delivery
Quarterly revenue and net income
Reported financial statements provide scale and earnings quality context around the headline EPS result.
Transmission matrix
Does price confirm delivery?
Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.
Current business context
Growth, quality and valuation
EPS growth15.8%year on year
Revenue growth12.4%year on year
Average surprise16.7%latest four quarters
SUE2.47standardised surprise
Net margin17.0%trailing basis
Cash conversion1.57xcash flow / net income
P/E44.1xcurrent snapshot
Data completeness100%alphavantage
Market context
Positioning into the event
Weekly close354.07 USDcompleted week
13-week return8.6%price momentum
Fair-value gap17.7%price versus current fair value
Relative strength12.7exchange benchmark
Trend signalActiveweekly architecture
Next-week stateUndecided54.6%
Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.
Reported evidence ledger
Quarter-by-quarter delivery and acceptance
Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / period23 Jul 202630 Jun 2026 · exact
EPS actual / estimate2.37 / 2.08USD
Surprise+13.9%Beat
EPS growth+28.8%year on year
Revenue / growth872300000+13.8% · USD
Next close / four weeks-8.4% / -completed weekly closes
ReadDivergedresult versus price sign
Reported / period23 Apr 202631 Mar 2026 · exact
EPS actual / estimate2.13 / 1.68USD
Surprise+26.8%Beat
EPS growth+46.9%year on year
Revenue / growth844900000+21.0% · USD
Next close / four weeks+11.8% / +10.7%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period12 Feb 202631 Dec 2025 · exact
EPS actual / estimate2.04 / 1.83USD
Surprise+11.5%Beat
EPS growth+12.1%year on year
Revenue / growth805000000+7.5% · USD
Next close / four weeks+0.6% / -1.2%completed weekly closes
ReadContainedresult versus price sign
Reported / period23 Oct 202530 Sep 2025 · exact
EPS actual / estimate1.96 / 1.71USD
Surprise+14.6%Beat
EPS growth+5.9%year on year
Revenue / growth804300000+7.7% · USD
Next close / four weeks+9.9% / -3.3%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period24 Jul 202530 Jun 2025 · exact
EPS actual / estimate1.84 / 1.54USD
Surprise+19.5%Beat
EPS growth+21.1%year on year
Revenue / growth766200000+9.1% · USD
Next close / four weeks+25.0% / +16.8%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period24 Apr 202531 Mar 2025 · exact
EPS actual / estimate1.45 / 1.26USD
Surprise+15.1%Beat
EPS growth-7.1%year on year
Revenue / growth698200000+0.4% · USD
Next close / four weeks+6.3% / +7.4%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period13 Feb 202531 Dec 2024 · exact
EPS actual / estimate1.82 / 1.71USD
Surprise+6.4%Beat
EPS growth-0.5%year on year
Revenue / growth748500000+2.2% · USD
Next close / four weeks-33.2% / -28.0%completed weekly closes
ReadDivergedresult versus price sign
Reported / period24 Oct 202430 Sep 2024 · exact
EPS actual / estimate1.85 / 1.49USD
Surprise+24.2%Beat
EPS growth-14.4%year on year
Revenue / growth746900000-0.1% · USD
Next close / four weeks+5.0% / +7.3%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period25 Jul 202430 Jun 2024 · exact
EPS actual / estimate1.52 / 1.73USD
Surprise-12.1%Miss
EPS growth-year on year
Revenue / growth702000000- · USD
Next close / four weeks-10.4% / -5.4%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period25 Apr 202431 Mar 2024 · exact
EPS actual / estimate1.56 / 1.29USD
Surprise+20.9%Beat
EPS growth-year on year
Revenue / growth695300000- · USD
Next close / four weeks-3.1% / -4.4%completed weekly closes
ReadDivergedresult versus price sign
Reported / period15 Feb 202431 Dec 2023 · exact
EPS actual / estimate1.83 / 1.78USD
Surprise+2.8%Beat
EPS growth-year on year
Revenue / growth732100000- · USD
Next close / four weeks-11.6% / -12.4%completed weekly closes
ReadDivergedresult versus price sign
Reported / period26 Oct 202330 Sep 2023 · exact
EPS actual / estimate2.16 / 1.86USD
Surprise+16.1%Beat
EPS growth-year on year
Revenue / growth747500000- · USD
Next close / four weeks-11.8% / -5.7%completed weekly closes
ReadDivergedresult versus price sign
Reproducible method
How the earnings dossier is measured
Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.
The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.
Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.
Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.
Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.